From: Plasma proteome changes in cardiovascular disease patients: novel isoforms of apolipoprotein A1
AMI (n = 27) | UAP (n = 26) | SAP (n = 38) | Control (n = 39) | |
---|---|---|---|---|
Age (years ± SEM) | 65 ± 14 | 72 ± 12 | 66 ± 10 | 67 ± 12 |
Males n (%) | 16 (59) | 18 (69) | 28 (74) | 14 (36) |
Hypertension n (%) | 12 (44) | 23 (88) | 34 (89) | 28 (72) |
Dyslipidemia n (%) | 14 (52) | 16 (62) | 32 (84) | 26 (67) |
Diabetes n (%) | 6 (22) | 7 (27) | 15 (39) | 8 (21) |
Smoking n (%) | 13 (48) | 5 (19) | 7 (18) | 4 (10) |
History of MI n | 2 | 5 | 12 | 2 |
History of stroke n | 0 | 4 | 4 | 1 |
BMI | 28.3 ± 3.3 | 27.9 ± 4.3 | 28.7 ± 5.3 | 27.5 ± 4.4 |
creatinine (μmol/L) | 87.7 ± 31.6 | 88.5 ± 26.5 | 87.5 ± 26.9 | 75.3 ± 17.6 |
treatment n (%): | ||||
Aspirin | 5 (19) | 14 (54) | 26 (68) | 20 (51) |
ADP blockers | 1 (4) | 6 (23) | 12 (32) | 6 (15) |
Beta blockers | 4 (15) | 10 (39) | 25 (66) | 20 (51) |
ACE inhibitors | 2 (7) | 16 (62) | 22 (58) | 12 (31) |
ARB | 2 (7) | 1 (4) | 5 (13) | 8 (21) |
Statins | 2 (7) | 11 (42) | 28 (74) | 20 (51) |
Ca blockers | 1 (4) | 5 (19) | 11 (29) | 6 (15) |
Warfarin | 2 (7) | 2 (8) | 4 (11) | 2 (5) |